Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.
HealthEquity, Inc is a health information services business based in the US. HealthEquity shares (HQY) are listed on the NASDAQ and all prices are listed in US Dollars. HealthEquity employs 2,931 staff and has a trailing 12-month revenue of around USD$724.4 million.
Since the stock market crash in March caused by coronavirus, HealthEquity's share price has had significant negative movement.
Its last market close was USD$52.05, which is 40.67% down on its pre-crash value of USD$87.73 and 51.31% up on the lowest point reached during the March crash when the shares fell as low as USD$34.4.
If you had bought USD$1,000 worth of HealthEquity shares at the start of February 2020, those shares would have been worth USD$624.34 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$775.02.
|Latest market close||USD$52.05|
|52-week range||USD$34.4 - USD$88.78|
|50-day moving average||USD$53.6029|
|200-day moving average||USD$54.994|
|Wall St. target price||USD$66.17|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.798|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-10-21)||-2.07%|
|1 month (2020-10-01)||0.37%|
|3 months (2020-07-29)||-3.16%|
|6 months (2020-04-29)||-13.15%|
|1 year (2019-10-29)||-13.18%|
|2 years (2018-10-29)||-38.71%|
|3 years (2017-10-27)||4.56%|
|5 years (2015-10-29)||56.45%|
Valuing HealthEquity stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of HealthEquity's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
HealthEquity's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 107x. In other words, HealthEquity shares trade at around 107x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
HealthEquity's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0636. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into HealthEquity's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
HealthEquity's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$202.8 million.
The EBITDA is a measure of a HealthEquity's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$724.4 million|
|Operating margin TTM||13.95%|
|Gross profit TTM||USD$325.9 million|
|Return on assets TTM||3.36%|
|Return on equity TTM||-1.68%|
|Market capitalisation||USD$4.3 billion|
TTM: trailing 12 months
There are currently 5.6 million HealthEquity shares held short by investors – that's known as HealthEquity's "short interest". This figure is 3.5% up from 5.4 million last month.
There are a few different ways that this level of interest in shorting HealthEquity shares can be evaluated.
HealthEquity's "short interest ratio" (SIR) is the quantity of HealthEquity shares currently shorted divided by the average quantity of HealthEquity shares traded daily (recently around 1.0 million). HealthEquity's SIR currently stands at 5.6. In other words for every 100,000 HealthEquity shares traded daily on the market, roughly 5600 shares are currently held short.
However HealthEquity's short interest can also be evaluated against the total number of HealthEquity shares, or, against the total number of tradable HealthEquity shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case HealthEquity's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 HealthEquity shares in existence, roughly 70 shares are currently held short) or 0.0852% of the tradable shares (for every 100,000 tradable HealthEquity shares, roughly 85 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against HealthEquity.
Find out more about how you can short HealthEquity stock.
We're not expecting HealthEquity to pay a dividend over the next 12 months.
Over the last 12 months, HealthEquity's shares have ranged in value from as little as $34.4 up to $88.78. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while HealthEquity's is 1.4313. This would suggest that HealthEquity's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
HealthEquity, Inc. providing technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves through employers; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was founded in 2002 and is headquartered in Draper, Utah.
Spend less $$$ on fares and MORE on fun when flying to Fukuoka, Japan or other cities worldwide.
Spend less $$$ on fares and MORE on fun when flying to Florence, Italy or other cities worldwide.
Spend less $$$ on fares and MORE on fun when flying to Edinburgh, Scotland or other cities worldwide.
Spend less $$$ on fares and MORE on fun when flying to Dublin, Ireland or other cities worldwide.
Spend less $$$ on fares and MORE on fun when flying to Dubai, UAE or other cities worldwide.
Spend less $$$ on fares and MORE on fun when flying to Denpasar, Indonesia or other cities worldwide.
Spend less $$$ on fares and MORE on fun when flying to Delhi, India or other cities worldwide.
Spend less $$$ on fares and MORE on fun when flying to Dalian, China or other cities worldwide.
Spend less $$$ on fares and MORE on fun when flying to Copenhagen, Denmark or other cities worldwide.
Spend less $$$ on fares and MORE on fun when flying to Chiang Mai, Thailand or other cities worldwide.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.